BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 33398161)

  • 1. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma.
    Wang R; Dang M; Harada K; Han G; Wang F; Pool Pizzi M; Zhao M; Tatlonghari G; Zhang S; Hao D; Lu Y; Zhao S; Badgwell BD; Blum Murphy M; Shanbhag N; Estrella JS; Roy-Chowdhuri S; Abdelhakeem AAF; Wang Y; Peng G; Hanash S; Calin GA; Song X; Chu Y; Zhang J; Li M; Chen K; Lazar AJ; Futreal A; Song S; Ajani JA; Wang L
    Nat Med; 2021 Jan; 27(1):141-151. PubMed ID: 33398161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
    Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
    Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma.
    Song S; Xu Y; Huo L; Zhao S; Wang R; Li Y; Scott AW; Pizzi MP; Wang Y; Fan Y; Harada K; Jin J; Ma L; Yao X; Shanbhag ND; Gan Q; Roy-Chowdhuri S; Badgwell BD; Wang Z; Wang L; Ajani JA
    J Exp Clin Cancer Res; 2021 Jun; 40(1):207. PubMed ID: 34162421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition.
    Ajani JA; Xu Y; Huo L; Wang R; Li Y; Wang Y; Pizzi MP; Scott A; Harada K; Ma L; Yao X; Jin J; Zhao W; Dong X; Badgwell BD; Shanbhag N; Tatlonghari G; Estrella JS; Roy-Chowdhuri S; Kobayashi M; Vykoukal JV; Hanash SM; Calin GA; Peng G; Lee JS; Johnson RL; Wang Z; Wang L; Song S
    Gut; 2021 Jan; 70(1):55-66. PubMed ID: 32345613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing.
    Zhang M; Hu S; Min M; Ni Y; Lu Z; Sun X; Wu J; Liu B; Ying X; Liu Y
    Gut; 2021 Mar; 70(3):464-475. PubMed ID: 32532891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma.
    Mizrak Kaya D; Nogueras-González GM; Harada K; Amlashi FG; Roy-Chowdhuri S; Estrella JS; Das P; Lee JH; Weston B; Bhutani MS; Matamoros A; Thomas I; Lin Q; Badgwell BD; Ajani JA
    J Surg Oncol; 2018 Mar; 117(4):678-684. PubMed ID: 29205363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of intratumoral heterogeneity with mutations and gene expression profiles.
    Sung JY; Shin HT; Sohn KA; Shin SY; Park WY; Joung JG
    PLoS One; 2019; 14(7):e0219682. PubMed ID: 31310640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer.
    Lee IS; Lee H; Hur H; Kanda M; Yook JH; Kim BS; Woo Y; Kodera Y; Kim K; Goel A
    Clin Cancer Res; 2021 Apr; 27(8):2292-2300. PubMed ID: 33558424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of an intra-tumor heterogeneity-related signature to predict prognosis of bladder cancer: a study based on single-cell RNA-seq.
    Zhou R; Liang J; Chen Q; Tian H; Yang C; Liu C
    Aging (Albany NY); 2021 Aug; 13(15):19415-19441. PubMed ID: 34339395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic value of cell-cycle-associated genes in gastric adenocarcinoma.
    Wang D; Zhu H; Guo M; Fan X; Hu S; Yan K; Sun J; Wang J; Li M; Xiao H; Liu Z
    BMC Gastroenterol; 2018 Jun; 18(1):81. PubMed ID: 29884122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq.
    Li Q; Wang R; Yang Z; Li W; Yang J; Wang Z; Bai H; Cui Y; Tian Y; Wu Z; Guo Y; Xu J; Wen L; He J; Tang F; Wang J
    Genome Med; 2022 Aug; 14(1):87. PubMed ID: 35962452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Reprogramming in Response to Alterations of Mitochondrial DNA and Mitochondrial Dysfunction in Gastric Adenocarcinoma.
    Chang TC; Lee HT; Pan SC; Cho SH; Cheng C; Ou LH; Lin CI; Lin CS; Wei YH
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal carcinomatosis in gastric cancer: Are Hispanics at higher risk?
    Choi AH; Ji L; Babcock B; Ramos V; Kwong MLM; Morgan JW; Selleck MJ; Langridge WHR; DeLeon M; Wall NR; Lum S; Pigazzi A; Dayyani F; Senthil M
    J Surg Oncol; 2020 Dec; 122(8):1624-1629. PubMed ID: 32901938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
    Zhang D; Zhou S; Liu B
    Biomed Res Int; 2020; 2020():7082408. PubMed ID: 32309437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum.
    Árnadóttir SS; Mattesen TB; Vang S; Madsen MR; Madsen AH; Birkbak NJ; Bramsen JB; Andersen CL
    PLoS One; 2020; 15(12):e0241148. PubMed ID: 33332369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between aneuploidy of chromosome 17, over-expression of TP53 and TOPIIalpha, and the clinicopathological features and diagnosis of gastric adenocarcinoma].
    Lu HZ; Wu YP; Luo W; Han YL; Cai Y; Xu X; Liang J; Liu SM; Wang MR
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):754-8. PubMed ID: 20021828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study.
    Liu H; Li F; Zhu Y; Li T; Huang H; Lin T; Hu Y; Qi X; Yu J; Li G
    Oncotarget; 2016 Jul; 7(28):43894-43906. PubMed ID: 27270314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma.
    Okada K; Fujiwara Y; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Takahashi T; Mori M; Doki Y
    J Surg Oncol; 2012 Jun; 105(8):780-5. PubMed ID: 22012575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-96-5p inhibition induces cell apoptosis in gastric adenocarcinoma.
    Zhou HY; Wu CQ; Bi EX
    World J Gastroenterol; 2019 Dec; 25(47):6823-6834. PubMed ID: 31885423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.